Skip to content
HeyJared

Roohi Mariam Peter

Reporter

Indexed articles, last 90 days
3
Latest publication
Jul 29, 2026
Outlet visibility, for Labiotech.eu
Top 5M sites
Earliest in this view
Jul 21, 2026
The latest indexed work is over 30 days old. There may be a gap in what we hold.

Latest articles

  1. Article · Jul 29, 2026 · Roohi Mariam Peter

    Meeting unmet needs: new treatments for gout race in the clinic (opens the original)

    Excerpt

    Read excerpt

    About half the people with gout don't have treatments that work for them. New drugs in the clinic could address this underserved population. The post Meeting unmet needs: new treatments for gout race in the clinic appeared first on Labiotech.eu. © Labiotech UG and Labiotech.eu. Unauthorized use and/or duplication of this material without express and written permission from this site’s author and/or owner is strictly prohibited. Excerpts and links may be used, provided that full and clear credit

  2. Article · Jul 27, 2026 · Roohi Mariam Peter

    Six TIL therapy companies to watch out for (opens the original)

    Excerpt

    Read excerpt

    The only TIL therapy approved so far is Amtagvi for melanoma. Here are six companies with promising TIL therapies in the clinic. The post Six TIL therapy companies to watch out for appeared first on Labiotech.eu. © Labiotech UG and Labiotech.eu. Unauthorized use and/or duplication of this material without express and written permission from this site’s author and/or owner is strictly prohibited. Excerpts and links may be used, provided that full and clear credit is given to Labiotech UG and

  3. Article · Jul 21, 2026 · Roohi Mariam Peter

    Roche’s new gene sequencer on the market: where do current players stand? (opens the original)

    Excerpt

    Read excerpt

    Roche's AXELIOS 1 enters next generation DNA sequencing. Can it or rivals unseat Illumina's long-standing market dominance? The post Roche’s new gene sequencer on the market: where do current players stand? appeared first on Labiotech.eu. © Labiotech UG and Labiotech.eu. Unauthorized use and/or duplication of this material without express and written permission from this site’s author and/or owner is strictly prohibited. Excerpts and links may be used, provided that full and clear credit is give

Publishing over time

Last 90 days. Choose a month to open its work.

Recurring subjects

Named in the text we hold. One piece can cover several.

Audience

Top 5M sites

For Labiotech.eu, the outlet · Measured Aug 1, 2026

Website popularity band, not a count of readers or article views.

About this data

Counts cover the work we have indexed. Tone needs enough text and a confident classification. Excerpts and episode notes are not full articles or transcripts.

Identity or attribution wrong? Suggest a correction.

See coverage about Roohi Mariam Peter